Theravance Biopharma Inc
TBPH
Market Cap$561.01M
Close$
$10.75
2.5% downside
Current Fair Value
2.5% downsideOvervalued by 2.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $561.01 Million |
|---|---|
| Enterprise Value | $512.67 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.15 |
| Beta | -0.08 |
| Outstanding Shares | 49,706,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.56 |
|---|---|
| PEG | -58.23 |
| Price to Sales | 11.03 |
| Price to Book Ratio | 3.68 |
| Enterprise Value to Revenue | 7.86 |
| Enterprise Value to EBIT | -11.07 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Theravance Biopharma Inc
CEO: Rick Winningham